Home Compare MDT vs SAN.PA
Stock Comparison · Clear separation

Medtronic vs Sanofi: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Medtronic carrying a narrow edge on growth. Sanofi still has the edge on growth, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

Growth points more clearly toward Sanofi, even if the broader score still leans toward Medtronic plc.

Trajectory Similarity
0.63
Moderately similar
Peer-set rank: #24
within Medtronic plc's functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.

The clearest structural overlap shows up in revenue stability and margin consistency.

Similarity drivers
revenue stabilitymargin consistency
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
MDT
Medtronic plc
51
Peer-Score
Signal qualityHigh
vs
SAN.PA
Sanofi
46
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: MDT vs SAN.PA Profitability 24 16 Stability 72 67 Valuation 74 59 Growth 33 51 MDT SAN.PA
Gap Ranking
#1 Growth +18
#2 Valuation +15
#3 Profitability +8
#4 Stability +5
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for MDT and SAN.PA Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer MDTSAN.PA Relative valuation Structural strength

The structural gap is limited here, but current pricing still leans against Sanofi.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
Sanofi sits in the stronger part of the group on growth, while Medtronic plc is closer to mid-pack.
Valuation
Both look solid on valuation, though Medtronic plc still holds the stronger peer position.
Growth — Dominant Gap
MDT
33
SAN.PA
51
Gap+18in favour of SAN.PA

The clearest distance comes from a stronger growth profile.

What else supports the lead

Medtronic plc also shows lower market-fundamental divergence, which makes the lead look less detached from the underlying business picture.

What this means for the comparison

Growth answers the page question more clearly than the overall score does.

Explore full peer positioning in AssetNext

Break down the MDT vs SAN.PA comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar growth-and-valuation comparisons

Explore how MDT and SAN.PA each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.